Get started
Author

Paul S. Covington

Eluxadoline for Irritable Bowel Syndrome with Diarrhea
2016 · Anthony J. Lembo, Brian E. Lacy, et al. · New England Journal of Medicine · 334
PDF
Eluxadoline Benefits Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 Study
2013 · Leonard S. Dove, Anthony Lembo, et al. · Gastroenterology · 148
PDF
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
2008 · P COVINGTON, R CHRISTOPHER, et al. · Clinical Therapeutics · 135
Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects
2008 · R CHRISTOPHER, P COVINGTON, et al. · Clinical Therapeutics · 122
Sphincter of Oddi Function and Risk Factors for Dysfunction
2017 · Elham Afghani, Simon K. Lo, et al. · Frontiers in Nutrition · 121
PDF
Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients
2013 · David A Andrae, Donald L Patrick, et al. · Health and Quality of Life Outcomes · 112
PDF
Liposomal prostaglandin E sub 1 in acute respiratory distress syndrome
1996 · Edward Abraham, Youn C Park, et al. · Critical Care Medicine · 95
Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
2016 · Brooks D Cash, Brian E Lacy, et al. · The American Journal of Gastroenterology · 88
Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use
2017 · Brian E Lacy, William D Chey, et al. · The American Journal of Gastroenterology · 55
Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline
2014 · J. Michael Davenport, Paul Covington, et al. · The Journal of Clinical Pharmacology · 44
PDF
Randomized, Double-Blind, Phase II, Multicenter Study Evaluating the Safety/Tolerability and Efficacy of JNJ-Q2, a Novel Fluoroquinolone, Compared with Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infection
2011 · Paul Covington, J. Michael Davenport, et al. · Antimicrobial Agents and Chemotherapy · 39
PDF
Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects
2010 · A. Karim, P. Covington, et al. · International Journal of Clinical Pharmacology and Therapeutics · 36
Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
2016 · N. Levy-Cooperman, G. McIntyre, et al. · Journal of Pharmacology and Experimental Therapeutics · 31
PDF
Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies
2017 · W. D. Chey, L. S. Dove, et al. · Alimentary Pharmacology & Therapeutics · 29
PDF
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea
2017 · Reginald V. Fant, Jack E. Henningfield, et al. · Clinical Gastroenterology and Hepatology · 20
PDF
Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials
2019 · Brian E. Lacy, Lucinda A. Harris, et al. · Therapeutic Advances in Gastroenterology · 17
Item-Level Assessment of the Irritable Bowel Syndrome Quality of Life Questionnaire in Patients With Diarrheal Irritable Bowel Syndrome
2014 · David A. Andrae, Paul S. Covington, et al. · Clinical Therapeutics · 13
PDF
Summary of Pharmacokinetics and Tissue Distribution of a Broad‐Spectrum Fluoroquinolone, JNJ‐Q2
2012 · J. Michael Davenport, Paul Covington, et al. · Clinical Pharmacology in Drug Development · 11
Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics
2017 · Thomas C. Marbury, Jolene Kay Berg, et al. · The Journal of Clinical Pharmacology · 9
PDF
929d Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety
2014 · Anthony Lembo, Scott Dove, et al. · Gastroenterology · 9
Effects of treatment with eluxadoline on abdominal pain in patients with IBS‐D: Additional post hoc analyses of Phase 3 trials
2020 · Anthony J. Lembo, Paul S. Covington, et al. · Neurogastroenterology & Motility · 8
PDF
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia
2013 · P. S. Covington, J. M. Davenport, et al. · Journal of Antimicrobial Chemotherapy · 8
PDF
Evaluation of Eluxadoline Effect on Cardiac Repolarization
2018 · Laura Bonifacio, Thomas L. Hunt, et al. · Clinical Pharmacology in Drug Development · 5
PDF
Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea
2018 · D. M. Brenner, L. S. Dove, et al. · Neurogastroenterology & Motility · 5
PDF
Su1378 Robustness of Eluxadoline for the Treatment of Irritable Bowel Syndrome With Diarrhea: Results From Phase 3 Composite Endpoint Assessments
2015 · Brian E. Lacy, Scott Dove, et al. · Gastroenterology · 5
Works count: 51
Citation count: 1,525
H-index: 16
I10-index: 18
Year
Topic
Type